Annual Shareholders Equity
$386.69 M
-$186.20 M-32.50%
December 31, 2023
Summary
- As of February 12, 2025, IONS annual stockholders equity is $386.69 million, with the most recent change of -$186.20 million (-32.50%) on December 31, 2023.
- During the last 3 years, IONS annual shareholders equity has fallen by -$356.60 million (-47.98%).
- IONS annual shareholders equity is now -73.71% below its all-time high of $1.47 billion, reached on December 31, 2019.
Performance
IONS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$662.47 M
+$398.77 M+151.22%
September 30, 2024
Summary
- As of February 12, 2025, IONS quarterly stockholders equity is $662.47 million, with the most recent change of +$398.77 million (+151.22%) on September 30, 2024.
- Over the past year, IONS quarterly shareholders equity has increased by +$347.01 million (+110.00%).
- IONS quarterly shareholders equity is now -54.97% below its all-time high of $1.47 billion, reached on December 31, 2019.
Performance
IONS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
IONS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.5% | +110.0% |
| 3 y3 years | -48.0% | -14.2% |
| 5 y5 years | -63.1% | -14.2% |
IONS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -49.9% | at low | -14.2% | +151.2% |
| 5 y | 5-year | -73.7% | at low | -55.0% | +151.2% |
| alltime | all time | -73.7% | +636.1% | -55.0% | +633.4% |
Ionis Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $662.47 M(+151.2%) |
| Jun 2024 | - | $263.70 M(-11.1%) |
| Mar 2024 | - | $296.51 M(-23.3%) |
| Dec 2023 | $386.69 M(-32.5%) | $386.69 M(+22.6%) |
| Sep 2023 | - | $315.46 M(-26.3%) |
| Jun 2023 | - | $428.30 M(-12.0%) |
| Mar 2023 | - | $486.57 M(-15.1%) |
| Dec 2022 | $572.89 M(-25.8%) | $572.89 M(-3.6%) |
| Sep 2022 | - | $594.36 M(-4.9%) |
| Jun 2022 | - | $624.73 M(-12.0%) |
| Mar 2022 | - | $709.57 M(-8.1%) |
| Dec 2021 | $771.74 M(+3.8%) | $771.74 M(+45.5%) |
| Sep 2021 | - | $530.54 M(-8.9%) |
| Jun 2021 | - | $582.67 M(-14.4%) |
| Mar 2021 | - | $680.56 M(-8.4%) |
| Dec 2020 | $743.28 M(-49.5%) | $743.28 M(-46.3%) |
| Sep 2020 | - | $1.38 B(+0.4%) |
| Jun 2020 | - | $1.38 B(+1.2%) |
| Mar 2020 | - | $1.36 B(-7.5%) |
| Dec 2019 | $1.47 B(+40.4%) | $1.47 B(+10.1%) |
| Sep 2019 | - | $1.34 B(+5.3%) |
| Jun 2019 | - | $1.27 B(+5.1%) |
| Mar 2019 | - | $1.21 B(+15.2%) |
| Dec 2018 | $1.05 B(+273.0%) | $1.05 B(+47.5%) |
| Sep 2018 | - | $710.55 M(+2.1%) |
| Jun 2018 | - | $696.25 M(+131.0%) |
| Mar 2018 | - | $301.39 M(+7.3%) |
| Dec 2017 | $281.01 M(+182.2%) | $281.01 M(-8.8%) |
| Sep 2017 | - | $307.97 M(+42.9%) |
| Jun 2017 | - | $215.57 M(+6.8%) |
| Mar 2017 | - | $201.81 M(+102.7%) |
| Dec 2016 | $99.56 M(-50.4%) | $99.56 M(-28.7%) |
| Sep 2016 | - | $139.64 M(+25.6%) |
| Jun 2016 | - | $111.21 M(-29.7%) |
| Mar 2016 | - | $158.16 M(-21.2%) |
| Dec 2015 | $200.79 M(-22.1%) | $200.79 M(-18.2%) |
| Sep 2015 | - | $245.41 M(-18.3%) |
| Jun 2015 | - | $300.32 M(+8.9%) |
| Mar 2015 | - | $275.85 M(+7.0%) |
| Dec 2014 | $257.78 M(-31.9%) | $257.78 M(-25.2%) |
| Sep 2014 | - | $344.77 M(-6.0%) |
| Jun 2014 | - | $366.86 M(-1.9%) |
| Mar 2014 | - | $374.10 M(-1.1%) |
| Dec 2013 | $378.39 M(+107.0%) | $378.39 M(-5.7%) |
| Sep 2013 | - | $401.45 M(+0.1%) |
| Jun 2013 | - | $401.08 M(+99.5%) |
| Mar 2013 | - | $201.09 M(+10.0%) |
| Dec 2012 | $182.77 M(+6.6%) | $182.77 M(+7.3%) |
| Sep 2012 | - | $170.28 M(+10.3%) |
| Jun 2012 | - | $154.31 M(+2.3%) |
| Mar 2012 | - | $150.87 M(-12.0%) |
| Dec 2011 | $171.43 M(-29.9%) | $171.43 M(-8.2%) |
| Sep 2011 | - | $186.82 M(-12.0%) |
| Jun 2011 | - | $212.22 M(-6.8%) |
| Mar 2011 | - | $227.70 M(-6.9%) |
| Dec 2010 | $244.54 M(-16.2%) | $244.54 M(-3.6%) |
| Sep 2010 | - | $253.71 M(-3.2%) |
| Jun 2010 | - | $262.23 M(-7.8%) |
| Mar 2010 | - | $284.44 M(-2.5%) |
| Dec 2009 | $291.72 M(+334.8%) | $291.72 M(-0.4%) |
| Sep 2009 | - | $293.00 M(+0.0%) |
| Jun 2009 | - | $292.85 M(+1.4%) |
| Mar 2009 | - | $288.85 M(+330.5%) |
| Dec 2008 | $67.09 M(+7594.0%) | $67.09 M(-1.4%) |
| Sep 2008 | - | $68.08 M(+15.3%) |
| Jun 2008 | - | $59.02 M(+8.1%) |
| Mar 2008 | - | $54.62 M(+6163.9%) |
| Dec 2007 | $872.00 K | $872.00 K(+275.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2007 | - | $232.00 K(-99.5%) |
| Jun 2007 | - | $47.28 M(-16.9%) |
| Mar 2007 | - | $56.90 M(-17.0%) |
| Dec 2006 | $68.56 M(+2472.7%) | $68.56 M(+4247.7%) |
| Sep 2006 | - | $1.58 M(-76.5%) |
| Jun 2006 | - | $6.71 M(-182.4%) |
| Mar 2006 | - | -$8.15 M(-405.8%) |
| Dec 2005 | $2.67 M(-103.7%) | $2.67 M(-34.0%) |
| Sep 2005 | - | $4.04 M(-103.3%) |
| Jun 2005 | - | -$124.19 M(+19.2%) |
| Mar 2005 | - | -$104.15 M(+44.4%) |
| Dec 2004 | -$72.13 M(-207.4%) | -$72.13 M(+308.9%) |
| Sep 2004 | - | -$17.64 M(-251.9%) |
| Jun 2004 | - | $11.61 M(-75.6%) |
| Mar 2004 | - | $47.55 M(-29.2%) |
| Dec 2003 | $67.18 M(-56.8%) | $67.18 M(-28.2%) |
| Sep 2003 | - | $93.51 M(-17.1%) |
| Jun 2003 | - | $112.83 M(-16.0%) |
| Mar 2003 | - | $134.28 M(-13.6%) |
| Dec 2002 | $155.48 M(-30.3%) | $155.48 M(-8.8%) |
| Sep 2002 | - | $170.57 M(-8.5%) |
| Jun 2002 | - | $186.37 M(-8.2%) |
| Mar 2002 | - | $202.91 M(-9.0%) |
| Dec 2001 | $223.10 M(+236.2%) | $223.10 M(+89.0%) |
| Sep 2001 | - | $118.03 M(+157.0%) |
| Jun 2001 | - | $45.93 M(+3.3%) |
| Mar 2001 | - | $44.47 M(-33.0%) |
| Dec 2000 | $66.37 M(+8195.8%) | $66.37 M(+0.6%) |
| Sep 2000 | - | $65.97 M(-5.4%) |
| Jun 2000 | - | $69.76 M(+45.7%) |
| Mar 2000 | - | $47.89 M(+5885.9%) |
| Dec 1999 | $800.00 K(-119.0%) | $800.00 K(-108.6%) |
| Sep 1999 | - | -$9.30 M(+78.8%) |
| Jun 1999 | - | -$5.20 M(-66.9%) |
| Mar 1999 | - | -$15.70 M(+273.8%) |
| Dec 1998 | -$4.20 M(-112.0%) | -$4.20 M(-135.3%) |
| Sep 1998 | - | $11.90 M(-6.3%) |
| Jun 1998 | - | $12.70 M(-48.4%) |
| Mar 1998 | - | $24.60 M(-29.5%) |
| Dec 1997 | $34.90 M(-40.2%) | $34.90 M(-15.7%) |
| Sep 1997 | - | $41.40 M(-1.4%) |
| Jun 1997 | - | $42.00 M(-17.6%) |
| Mar 1997 | - | $51.00 M(-12.7%) |
| Dec 1996 | $58.40 M(-23.1%) | $58.40 M(-2.7%) |
| Sep 1996 | - | $60.00 M(-8.8%) |
| Jun 1996 | - | $65.80 M(-8.0%) |
| Mar 1996 | - | $71.50 M(-5.8%) |
| Dec 1995 | $75.90 M(+65.0%) | $75.90 M(+41.6%) |
| Sep 1995 | - | $53.60 M(+41.1%) |
| Jun 1995 | - | $38.00 M(-6.2%) |
| Mar 1995 | - | $40.50 M(-12.0%) |
| Dec 1994 | $46.00 M(-21.4%) | $46.00 M(-11.4%) |
| Sep 1994 | - | $51.90 M(-9.4%) |
| Jun 1994 | - | $57.30 M(-9.2%) |
| Mar 1994 | - | $63.10 M(+7.9%) |
| Dec 1993 | $58.50 M(+47.0%) | $58.50 M(+33.9%) |
| Sep 1993 | - | $43.70 M(-9.3%) |
| Jun 1993 | - | $48.20 M(-8.9%) |
| Mar 1993 | - | $52.90 M(+32.9%) |
| Dec 1992 | $39.80 M(-32.7%) | $39.80 M(-11.8%) |
| Sep 1992 | - | $45.10 M(-9.6%) |
| Jun 1992 | - | $49.90 M(-7.8%) |
| Mar 1992 | - | $54.10 M(-8.5%) |
| Dec 1991 | $59.10 M(+3376.5%) | $59.10 M(+90.0%) |
| Sep 1991 | - | $31.10 M(-7.2%) |
| Jun 1991 | - | $33.50 M(+161.7%) |
| Mar 1991 | - | $12.80 M(+652.9%) |
| Dec 1990 | $1.70 M | $1.70 M |
FAQ
- What is Ionis Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual shareholders equity year-on-year change?
- What is Ionis Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Ionis Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of IONS is $386.69 M
What is the all time high annual shareholders equity for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual stockholders equity is $1.47 B
What is Ionis Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, IONS annual stockholders equity has changed by -$186.20 M (-32.50%)
What is Ionis Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of IONS is $662.47 M
What is the all time high quarterly shareholders equity for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly stockholders equity is $1.47 B
What is Ionis Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, IONS quarterly stockholders equity has changed by +$347.01 M (+110.00%)